These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16286950)
1. PHARMAC responds on long-acting inhalers for COPD. Metcalfe S; Dougherty S N Z Med J; 2005 Nov; 118(1225):U1743. PubMed ID: 16286950 [No Abstract] [Full Text] [Related]
2. Long-acting inhaled bronchodilators for COPD--lack of logic continues. Jones D N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360 [TBL] [Abstract][Full Text] [Related]
3. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease. Gershon AS; Wang L; To T; Luo J; Upshur RE COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
5. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011 [TBL] [Abstract][Full Text] [Related]
6. Tiotropium effective in treatment of COPD. Kripke C Am Fam Physician; 2005 Dec; 72(11):2219-20. PubMed ID: 16345146 [No Abstract] [Full Text] [Related]
7. Triple inhalers for obstructive airways disease: will they be useful? Barnes PJ Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649 [No Abstract] [Full Text] [Related]
8. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease. Chen AM; Bollmeier SG; Finnegan PM Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624 [TBL] [Abstract][Full Text] [Related]
9. [Tiotropium: new about known]. Stepanian IE Ter Arkh; 2008; 80(3):82-4. PubMed ID: 18441692 [No Abstract] [Full Text] [Related]
10. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect]. MMW Fortschr Med; 2002 Jun; 144(26):52. PubMed ID: 12154479 [No Abstract] [Full Text] [Related]
12. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions. Anzueto A Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899 [TBL] [Abstract][Full Text] [Related]
13. Long-acting beta-agonists in asthma. Agarwal A N Engl J Med; 2009 Jul; 361(2):208; author reply 209. PubMed ID: 19587350 [No Abstract] [Full Text] [Related]
14. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs. Drescher GS; Carnathan BJ; Imus S; Colice GL Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702 [TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM; White CM; Coleman CI Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [TBL] [Abstract][Full Text] [Related]
16. On comparing different devices of inhalation products. GarcĂa Arieta A Respir Med; 2009 Nov; 103(11):1774-5; author reply 1776. PubMed ID: 19692222 [No Abstract] [Full Text] [Related]
17. Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S Thorax; 2006 Jan; 61(1):91. PubMed ID: 16396956 [No Abstract] [Full Text] [Related]
18. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506 [TBL] [Abstract][Full Text] [Related]